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Abstract
Background: Data analysis and visualization is an essential tool for exploring and communicating findings in
medical research, especially in epidemiological surveillance.
Results: Data on COVID-19 diagnosed cases and mortality, from January 1st, 2020, onwards is collected automatically
from the European Centre for Disease Prevention and Control (ECDC). We have developed a Shiny application for data
visualization and analysis of several indicators to follow the SARS-CoV-2 epidemic using ECDC data. A country-specific
tool for basic epidemiological surveillance, in an interactive and user-friendly manner. The available analyses cover time
trends and projections, attack rate, population fatality rate, case fatality rate, and basic reproduction number.
Conclusions: The COVID19-World online web application systematically produces daily updated country-specific data
visualization and analysis of the SARS-CoV-2 epidemic worldwide. The application may help for a better understanding
of the SARS-CoV-2 epidemic worldwide.
Keywords: SARS-CoV-2, COVID-19, Epidemic, Data visualization, Poisson regression, Mortality, Mortality rate, Case fatality
rate, Basic reproduction number
Background
The first confirmed case of SARS-CoV-2 in China was
reported to the WHO country office in China on
December 31st, 2019 [1]. The outbreak was declared a
public health emergency of international concern on
January 30th, 2020 [1]. Since then, up to June 17th, more
than 210 countries have been affected worldwide, 8,162,
276 people have been diagnosed, 443,685 have died due
to the SARS-CoV-2 pandemic [2] and numbers are still
growing.
Data analysis and visualization is an essential tool for
exploring and communicating findings in medical research,
especially in epidemiological surveillance [3]. It can help
researchers and policymakers to identify trends that could
be overlooked if the data were reviewed in tabular form.
Here, we present the worldwide extension of a previous
Shiny application for data visualization and analysis of sev-
eral indicators to follow the SARS-CoV-2 epidemic in Spain
[4]. With this extension, conceived as an independent tool,
specific visualizations for any country worldwide can be
produced to assess the time evolution of the pandemic, be-
yond the usual dashboards showing geographic variations
[5]. Data is directly downloaded from the European Centre
for Disease Prevention and Control (ECDC) each time that
a user interacts with the application. Therefore, we have
now developed the COVID19-World application, which
systematically produces country-specific data visualization
and analysis of trends and short-term projections for
diagnosed cases and deaths (both for cumulative and
incident data), case fatality rate, infection time, and basic
reproduction number.
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The COVID19-World application has been developed in
RStudio [6], version 1.2.5033, using the Shiny package,
version 1.4.0. Shiny offers the ability to develop a graphical
user interface (GUI) that can be run locally or deployed
online. Last is particularly beneficial to show and commu-
nicate updated findings to a broad audience. All the ana-
lyses have been carried out using R [7], version 3.6.3. The
key R packages used in the tool implementation include
dplyr, xlsx, and vroom for data management, sjPlot, and
EpiEstim for data analysis, shinydashboard, shinyFeedback,
shinycssloaders, and kableExtra for application enhance-
ment and plotly for the graphical displays. The application
is freely available online at [https://ubidi.shinyapps.io/
covid19world], being the source code available under re-
quest through Github at [https://github.com/ubidi/covid1
9world]. Menus, tabs, and outputs are available in English,
Spanish, and Catalan.
The European Centre for Disease Prevention and Con-
trol (ECDC) data file offers a downloadable file updated
daily with the latest available public data on COVID-19
per day and country. Data is collected based on reports
from health authorities worldwide by the ECDC’s Epi-
demic Intelligence team. The application has an auto-
mated process to update data and all analyses each time
a user connects to the app. Data on COVID-19 diag-
nosed cases and mortality, from January 1st, 2020, on-
wards is collected at [https://www.ecdc.europa.eu/en/
publications-data/download-todays-data-geographic-dis-
tribution-covid-19-cases-worldwide]. The downloadable
dataset is updated daily and contains the latest available
public data on COVID-19 worldwide. Countries with a
population under 500,000 inhabitants are not included.
The application is user friendly, based on intuitive
menus to show data visualization for each of the ana-
lyses implemented, once a specific country has been
chosen from the top dialog box (Fig. 1).
Trends and projections
Trends for the number of diagnosed cases and deaths
are estimated using Poisson regression models [8],
allowing for over-dispersion [9]. A time-dependent poly-
nomial function is used to estimate the expected number
of cases. As the epidemic evolved the degree of the
polynomial function was increased. The current
model allows for a fourth-degree polynomial function,
as follows:
log E ctð Þð Þ ¼ β0 þ β1tþ β2t2 þ β3t3 þ β4t4
where t = 1, 2, …, T, represents the time unit (from the
first observed day until the last, T consecutive days in
total), and ct is the number of events. The estimated re-
gression parameters and their standard errors are used
to obtain the short-term projections, up to 3 days, and
their 95% CI.
Nevertheless, these models are being regularly evalu-
ated by checking the overdispersion parameter, the sum
of Pearson residuals, and the deviance, in case a model
reformulation with a better fit is necessary during the
epidemic.
Fig. 1 Home page of the COVID19-World application, for comprehensive country-specific data visualization for the SARS-CoV-2 epidemic.
Available at [https://ubidi.shinyapps.io/covid19world/]
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Case fatality rate
The case fatality rate is defined as the ratio between the
number of deaths and the number of diagnosed cases
[10]. Thus, an offset is fitted into the Poisson regression
model, also allowing for overdispersion, as the logarithm
of the diagnosed cases:
log E mtð Þð Þ ¼ β0 þ β1tþ β2t2 þ β3t3 þ β4t4
þ log ctð Þ
where mt is the daily number of deaths, and ct is the
daily number of diagnosed cases. Case fatality rates are
also calculated for the same age groups.
We should acknowledge that it is not possible to make
an accurate estimate of the case fatality rates due to the
underreporting of cases diagnosed in official statistics
[11]. Nonetheless, the estimation and monitoring of the
case fatality rates monitoring are of especial interest in
the current epidemic scenario.
Infection time
Infection time, estimating the incubation period for
COVID-19 between the interval of exposure to SARS-
CoV-2 and the date of diagnosis is computed following
the approach of Lauer et al. [12], who have recently ana-
lyzed the incubation period for COVID-19 in a cohort of
symptomatic patients. For each patient, they collected
the interval of exposure to SARS-CoV-2 and the date of
appearance of symptoms. They assumed that the incuba-
tion time would follow, as in other viral respiratory tract
infections, a Lognormal distribution.
Lognormal mu; sigma2
  ¼ Lognormal 1:621; 0:418ð Þ
We have replicated this distribution in the group of di-
agnosed cases to approximate the date of exposure to
SARS-CoV-2 recursively:
q ið Þ ¼
X14
j¼1
P jð Þ  c jþi
where p is the number of diagnosed cases on a day i; q
is the number of infected cases on day i-j; j = 1, 2, …, 14
is the maximum time it is expected that the disease can
develop; and P(j) is the probability of presenting symp-
toms on day j according to a Lognormal probability distri-
bution with the parameters defined by Lauer et al. [12]
To estimate the last 14 days, since the information on
the diagnosed cases was not available for the forthcom-
ing days, a fourth-degree polynomial model was used to
project diagnosed cases. These latest estimates are dis-
played in the application with a different color.
Basic reproduction number
The basic reproduction number (R0) is the average num-
ber of secondary cases of disease caused by a single in-
fected individual over his or her infectious period [13].
This statistic, which is time and situation-specific, is
commonly used to characterize pathogen transmissibility
during an epidemic. The monitoring of R0 over time
provides feedback on the effectiveness of interventions
and on the need to intensify control efforts. The goal of
control efforts is to reduce the R0 below the threshold
value of 1 and as close to 0 as possible to control the
epidemic. Here, we used the R package EpiEstim to
estimate the basic reproduction number through the
Wallinga and Teunis method [13], which assumes a
gamma distribution for the serial interval. The serial
interval is the time between the onset of symptoms in a
primary case and the onset of symptoms of secondary
cases, which is needed to estimate R0 throughout the
epidemic. The mean and standard deviation of the serial
interval distribution can vary depending on the disease
[13]. Recently, Nishiura et al. [14] estimated a mean and
standard deviation for the COVID-19 serial interval dis-
tribution of 4.7 and 2.9 days, respectively, being these
the values we are using in our analysis for the gamma a
priori distribution.
The goodness of fit of estimated models is evaluated
to provide a better fit of the data during the epidemic. A
deviance analysis is performed to compare the model’s
fit. Moreover, to quantify the model error Poisson over-
dispersion parameter, the sum of Pearson’s residuals and
deviances are shown.
Results
Up to June 17th, an exponential increase in the global
number of COVID-19 cases was observed (Fig. 2a and
b). The shape of the curve on daily incident cases and
mortality curves in most countries shows a propagated
epidemic pattern (for example the United Kingdom and
the United States in Fig. 3a and b). In a propagated out-
break, there is no common source and the outbreak
spreads from person to person. The classic propagated
curve has a series of progressively taller peaks, each an
incubation period apart, which may lead to multiple
waves of infection if secondary cases occur. However, in
the case of SARS-Cov-2, waves of cases seem to overlap
due to high viral transmission and the curve is more
bell-shaped with a large cue. In most countries, the suc-
cessive waves involve more and more people, until lock-
down or social distancing measures were implemented.
In the counterpart, the case fatality rate ranges from
2% of South Korea to 15% of Italy and globally is 5.5%
(Fig. 4a, b, and c respectively). This variation on the case
fatality rate, in our opinion, could be explained by
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variability in the testing effort of each country to identify
cases.
The estimated infection time has been globally re-
duced over the epidemic period (Fig. 2c), and the global
basic reproductive number is currently around 1, except
in those countries who are experimenting with a second
wave.
Discussion
The application allows the use of epidemiological indica-
tors to a better understanding of the evolution of the
COVID-19 epidemic in 167 countries affected. However,
we should note that it has been developed mainly for de-
scriptive purposes. Therefore, we avoided using complex
mathematical models to predict an uncertain future with
uncertain data [15]. We choose to use a classical ap-
proach fitting Poisson regression models, commonly
used in epidemiological research [8, 16], which not only
is parsimonious but also showed reasonable goodness of
fit. To go beyond epidemiological information, we add
some tabs with relevant statistical information about esti-
mated models. The target audience of this web application
is wide. It includes scientists, researchers, policymakers,
journalists, and the general public with a special concern
on the SARS-CoV-2 epidemic. Since publication to date,
our application had received more than 6 thousand visits
from all around the world, but mainly from Europe and
the United States.
Tracking the SARS-CoV-2 epidemic spread has become
a topic of great interest. There are several apps,
Fig. 2 Standard output display of the COVID19-World application (results updated to June 17th, 2020) trend analysis and its 3-day projection at
the global scale of cumulate incident cases (a); daily incident cases (b); and basic reproduction number (c)
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dashboards, and maps on the internet showing local, na-
tional, and international figures. Among the most popular
the Johns Hopkins University web offers a worldwide view
on a map with the cumulate number of confirmed cases,
deaths, and recovered worldwide and by country and
state/region, but not in all countries. The World Health
Organization has its dashboard showing more or less the
same information on confirmed cases and deaths by coun-
try. Other applications focus its figures on predictions. Is
the case of the web developed by the Institute for Health
Metrics and Evaluation (IHME) of the University of
Washington. On its web, you can see current data and
projections on cumulate and daily cases and deaths in the
United States and the European Economic Area. More-
over, they used a mixed-effects non-linear regression
framework to estimate the trajectory of the cumulative
and daily death rate as a function of the implementation
of social distancing measures.
The choice of reliable data sources is complex and not
absent from controversy [17, 18]. Our main data source
is provided daily by the ECDC (19) and we mainly chose
epidemiological indicators based on those which could
be derived from diagnosed cases and daily deaths.
We should acknowledge that the application does not
take into account the changes in the definition of a case
diagnosed by COVID-19, nor the population exposed.
So, the number of events is modeled directly instead of
the incidence rate, assuming that the entire population
is at risk, except for the case fatality rate. Moreover, the
analyses are not free from the biases linked to the source
of information provided by the ECDC. For example, in
several countries, it can take some weeks until death cer-
tificates are available in databases. Hence, estimates
might not be accurate due to the underreporting of diag-
nosed cases and mortality in official statistics.
Conclusions
The COVID19-World is a web-based application that
comes to fill a gap, presenting a set of useful tools for
updated country-specific analysis and visualization of
epidemiological indicators of the COVID-19 epidemic
worldwide. The web application facilitates a better un-
derstanding of the evolution of the epidemic in each
country and might be useful for country-specific epi-
demiological surveillance.
Fig. 3 Propagated epidemic patron in the United Kingdom (a) and the United States (b)
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Availability and requirements
Project name: COVID-19 WORLD.
Project home page: https://ubidi.shinyapps.io/covid1
9world/
Operating system: Platform independent.
Programming language: R.
Other requirements: Any web browser, or RStudio
with libraries shiny, dplyr, xlsx, vroom, sjPlot, EpiEstim,
shinydashboard, shinyFeedback, shinycssloaders, and
kableExtra.
License: published under the GNU General Public
License Version 2.
Any restrictions to use by non-academics: Commercial
organizations are welcome to contact the author prior to
use.
Abbreviations
COVID-19: Coronavirus disease 2019; GLP: General public license; GNU: GNU’s
not unix!; GUI: Graphical user interface; SARS-CoV-2: Severe acute respiratory
syndrome coronavirus 2
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Availability of data and materials
Data is available at ECDC “Download today’s data on the geographic
distribution of COVID-19 cases worldwide” https://www.ecdc.europa.eu/en/
publications-data/download-todays-data-geographic-distribution-covid-19-
cases-worldwide. Source code is available under request through Github at
[https://github.com/ubidi/covid19world].
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